Abstract:Carcinogenic tobacco-specific nitrosamines (TSNAs) such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) are found only in tobacco and derived products. Food and Drug Administration of the United States (US FDA) lists NNK as one of the 93 harmful and potentially harmful constituents (HPHCs) found in tobacco products and tobacco smoke. The aim of this study was to use the urinary concentration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), a major metabolite of NNK, to quantitatively estimate exposure to NNK in the US general population. In 2011–2012, the Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey (NHANES) collected urine and serum samples from a representative sample of US residents. We used a serum cotinine cutoff of 10 ng/ml with combination of questionnaire data to select non-users from cigarette users and used self-reported data to determine different tobacco product user groups. We estimated the absorbed total daily dose of NNK using a probabilistic method based on a two-compartment model. The geometric mean (GM) for the daily dose of NNK among smokers aged 12–16 years was significantly higher than that for non-users at the same age stage exposed to second-hand smoke (SHS) ( P <0.001). Among those exposed to SHS, the GM for daily dose of NNK in young children (6–11 years) was nearly three times of those for adults in the age range 21–59 years. Among cigarette users, non-Hispanic Whites had the highest NNK daily dose and Mexican Americans had the lowest levels. Exclusive snuff or chewing product users had significantly higher daily dose of NNK than did cigarette smokers. Our study found that the maximum daily dose of NNK for children aged from 6 to 11 years and that for a significant percentage of cigarette users, chewing product and snuff users were higher than an estimated provisional “reference” risk level.

Metabolic study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to the enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in vitro in human bronchial epithelial cells using chiral capillary electrophoresis

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.

Study of the metabolism on tobacco-specific N -nitrosamines in the rabbit by solid-phase extraction and liquid chromatography–tandem mass spectrometry

Computational Evidence for Α-Nitrosamino Radical As Initial Metabolite for Both the P450 Dealkylation and Denitrosation of Carcinogenic Nitrosamines B

Analysis of N′-nitrosonornicotine and Its Metabolites in Rabbit Blood with Liquid Chromatography/tandem Mass Spectrometric Method

CHIRAL RP-HPLC ASSAY FOR PROPAFENONE ENANTIOMERS IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN VITRO METABOLISM

Use of Autoclave Extraction-Supercritical Fluid Chromatography/tandem Mass Spectrometry to Analyze 4-(Methylintrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Tobacco.

On-line concentration and determination of tobacco-specific N-nitrosamines by cation-selective exhaustive injection-sweeping-micellar electrokinetic chromatography.

Metabolism Study On Tobacco-Specific N-Nitrosamines In Rabbit By Solid-Phase Extraction And Liquid Chromatography-Electrospray

Separation of N-nitrosonornicotine Isomers and Enantiomers by Supercritical Fluid Chromatography Tandem Mass Spectrometry

Enantioseparation of nornicotine in tobacco by ultraperformance convergence chromatography with tandem mass spectrometry.

NNAL, a major metabolite of tobacco-specific carcinogen NNK, promotes lung cancer progression through deactivating LKB1 in an isomer-dependent manner

Determination of Tobacco‐specific N‐nitrosamines in Rabbit Serum by Capillary Zone Electrophoresis and Capillary Electrophoresis‐electrospray Ionization‐mass Spectrometry with Solid‐phase Extraction

Chiral determination of nornicotine, anatabine and anabasine in tobacco by achiral gas chromatography with (1S)-(-)-camphanic chloride derivatization: Application to enantiomeric profiling of cultivars and curing processes

Genetic Variability in the Metabolism of the Tobacco‐specific Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK) to 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)

SPE-HPLC-MS/MS Method for the Trace Analysis of Tobacco-Specific N-nitrosamines and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Rabbit Plasma Using Tetraazacalix[2]arene[2]triazine-Modified Silica As a Sorbent.

Genotoxicity Study on Nicotine and Nicotine-Derived Nitrosamine by Accelerator Mass Spectrometry

An Update on the Formation in Tobacco, Toxicity, and Carcinogenicity of N' -Nitrosonornicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone

Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines ( N -nitrosonornicotine and N -nitrosoanabasine) in human cells, partially different CYPs being activating enzymes

Assessing Exposure to Tobacco-Specific Carcinogen NNK Using Its Urinary Metabolite NNAL Measured in US Population: 2011–2012